You are here

Article Text

Article menu
Download PDFPDF
Commentary
Quest for immunological biomarkers in the management of CHB patients

https://doi.org/10.1136/gutjnl-2023-329437

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Twitter @bertoletti_lab

    • Contributors Both authors equally contributed to the manuscript.

    • Funding This publication was supported by the Singapore Ministry of Health’s National Medical Research Council MOH-000019 (MOH-StaR17Nov-0001).

    • Competing interests AB and NLB reported a patent for a method to monitor SARS-CoV-2-specific T cells in biological samples pending and are the co-founders of T Cell Diagnostic (TCD).

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles